Oss, Netherlands

Jacobus Albertus Maria Peters

This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacobus Albertus Maria Peters. Retrieved from https://idiyas.com/inventor/jacobus-albertus-maria-peters

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacobus Albertus Maria Peters: Innovator in Anticoagulant Research

Introduction

Jacobus Albertus Maria Peters is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticoagulant properties. His work is essential in addressing thrombin-related diseases, which pose serious health risks.

Latest Patents

Peters holds a patent for serine protease inhibitors. The invention relates to a compound having a specific formula, wherein A, B, X, Y, and r are defined in the description. This compound, or its prodrug or pharmaceutically acceptable salt, exhibits anticoagulant activity and can be utilized in treating or preventing thrombin-related diseases. He has 1 patent to his name.

Career Highlights

Jacobus Peters is associated with Akzo Nobel N.V., a leading company in the chemical and pharmaceutical industry. His role at the company has allowed him to focus on innovative research and development in the field of anticoagulants.

Collaborations

Peters has collaborated with Anton Egbert Peter Adang, enhancing the research and development efforts in their shared field of expertise.

Conclusion

Jacobus Albertus Maria Peters is a distinguished inventor whose work in anticoagulant research has the potential to significantly impact medical treatments for thrombin-related diseases. His contributions to the field are noteworthy and continue to inspire further innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…